Effects of C-reactive protein and pentosan polysulphate on human complement activation

Immunology

Volumn 106, Issue 3, 2002, Pages 381-388

  Klegeris, Andis ^a   Singh, Edith A ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; DEXTRAN SULFATE; FUCOIDIN; HEPARIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN G; PENTOSAN POLYSULFATE; REACTIVE OXYGEN METABOLITE; XANTHINE; XANTHINE OXIDASE;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL SURFACE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN BINDING; QUANTITATIVE ASSAY;

C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; HUMANS; PENTOSAN SULFURIC POLYESTER; TUMOR CELLS, CULTURED;

EID: 0036302184     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01425.x     Document Type: Article

References (43)

1. Controlling the complement system in inflammation
2. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries
3. Generation of C-reactive protein and complement components in atherosclerotic plaques
4. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
5. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction
6. Human heart generates complement proteins that are upregulated and activated after myocardial infarction
7. The role of complement in disorders of the nervous system
8. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study
9. Immune system response in Alzheimer's disease
10. Complement activation by beta-amyloid in Alzheimer disease
11. Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
12. Role of complement in aetiology of Pick's disease?
13. Complement inhibitors in myocardial ischemia/reperfusion injury
14. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment
15. The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart
16. Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate
17. 3H-pentosanpolysulphate to the urinary tract in rats
18. Interstitial cystitis
19. C-reactive protein-like immunoreactivity in the neurofibrillary tangles of Alzheimer's disease
20. Demonstration of CRP immunoreactivity in brains of Alzheimer's disease: Immunohistochemical study using formic acid pretreatment of tissue sections
21. Human neurons generate C-reactive protein and amyloid P. Upregulation in Alzheimer's disease
22. Structure and function of pentraxins
23. C-reactive protein: Structural biology, gene expression, and host defense function
24. Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin
25. CRP-mediated activation of complement in vivo. Assessment by measuring circulating complement-C-reactive protein complexes
26. Topology and structure of the C1q-binding site on C-reactive protein
27. Function of C-reactive protein
28. Complement activation occurs on subendothelial extracellular matrix and is initiated by retraction or removal of overlying endothelial cells
29. Interaction of C-reactive protein with liposomes. III. Membrane requirements for binding
30. Complement activation by C-reactive protein on the HEp-2 cell substrate
31. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library
32. Binding kinetics, structure-activity relationship, and biotransformation of the complement inhibitor compstatin
33. Inhibitory action of 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide (PK 11195) on some mononuclear phagocyte functions
34. Biologic activity of aggregated γ-globulin. II. A study of various methods for aggregation and species differences
35. Free radical effects on myocardial membrane microviscosity
36. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium
37. Interaction of C-reactive protein and complement with liposomes. II. Influence of membrane composition
38. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes
39. Inhibition of the interaction between the complement component Clq and immune complexes
40. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
41. Protection and injury. The differing roles of complement in the development of glomerular injury
42. Upregulated production and activation of the complement system in Alzheimer's disease brain